Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism

Ann Neurol. 2002 Aug;52(2):257-8; author reply 258. doi: 10.1002/ana.10270.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Age of Onset
  • Ataxins
  • Dihydroxyphenylalanine / therapeutic use*
  • Dopamine Agents / therapeutic use*
  • Drug Resistance
  • Humans
  • Nerve Tissue Proteins
  • Parkinsonian Disorders / drug therapy*
  • Parkinsonian Disorders / epidemiology
  • Parkinsonian Disorders / genetics*
  • Proteins / genetics*

Substances

  • Ataxins
  • Dopamine Agents
  • Nerve Tissue Proteins
  • Proteins
  • Dihydroxyphenylalanine